Uni research for breast cancer drug
LONDON: Scientists have embarked on a research project to test whether an existing drug can offer a new treatment to people with incurable breast cancer that has spread to the brain.
Secondary breast cancer occurs when the cancer has spread from the breast to other parts of the body, where it becomes incurable. During the study, researchers will assess whether the drug talazoparib can help kill the cancer cells.
Talazoparib is a type of drug called a PARP inhibitor which works by preventing cancer cells from repairing, forcing them to die. RCSI University experts in Dublin will use tumours and breast cancer cells donated by patients to see whether talazoparib is effective in treating secondary breast cancer in the brain.